Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097627 · ClinicalTrials.gov registry record · Phase 1
Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
A Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03097627: Completed Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple, sponsored by Brigham and Women's Hospital.
NCT03097627 is a Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03097627, a Phase 1 study of Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.
Primary Outcome
In this initial proof-of-concept pilot trial for patients undergoing surgical resection of suspicious intra-thoracic lesions, the investigators will demonstrate that IV ICG is a safe and feasible method for lesion localization. The investigators will demonstrate this across a variety of intra-thoracic pathology including primary lung cancer, pulmonary metastases, mesothelioma, mediastinal tumors, and potentially infectious sources such as aspergilloma. The investigators will measure safety based
Conditions Studied
Interventions
- DRUG ICG Intervention
- DEVICE Near Infrared Camera
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2016-10-28 |
| Phase | Phase 1 |
What the finished NCT03097627 record still lists
NCT03097627 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Pulmonary Nodule, Solitary appearing as the primary indexed condition, and to 2 interventions - of which ICG Intervention is the first listed.
NCT03097627 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03097627 about?
NCT03097627 is a clinical study titled "Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions". This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.
What is the current status of trial NCT03097627?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2016-02-01. Estimated completion is 2016-10-28.
What conditions does trial NCT03097627 study?
This clinical trial studies the following conditions: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple.
What interventions are being tested in trial NCT03097627?
The interventions under investigation include: ICG Intervention (DRUG), Near Infrared Camera (DEVICE).
Who is sponsoring clinical trial NCT03097627?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03097627 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Nodule, Solitary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03097627's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI